Biobanking: Strengthening Uganda’s Rapid Response to COVID-19 and Other Epidemics

SARS-CoV-2 is a fatal disease of global public health concern. Measures to reduce its spread critically depend on a timely and accurate diagnosis of virus-infected individuals.

During epidemics and pandemics like COVID-19, the establishment of a sustainable biobanking mechanism for the standardized collection, characterization, and archiving of specimens, and sharing of these specimens to facilitate diagnostic testing, therapeutics development, and knowledge discovery is necessary. As the number of COVID-19 cases and fatalities continue to mount in Uganda, CoV-Bank will continue to support local and international researchers as they respond to the pandemic.

Read this article, where the authors show how a biobank has been a critical resource in the rapid response to coronavirus disease of 2019 (COVID-19) in Uganda.

 

Leave a Comment

Prove that you are human! *

    By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

    The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
    Feel free to Contact Us for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


      Avoid Gmail, Yahoo, etc. please.

      By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        The Features PDF has been emailed to you.
        Feel free to "Schedule a Demo" or "Contact Us" for any questions.

        Srikanth Adiga,
        C.E.0, OpenSpecimen
        Email: sri@krishagni.com

          By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.